Minneapolis, MN – According to filings with the U.S. Securities and Exchange Commission, SynerFuse is raising $30,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Justin Zenanko played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About SynerFuse
SynerFuse is long-term pain management without the use of addictive opioids. SynerFuse combines two FDA-approved technologies and synergistically fuses both in order to attack the problem of long-term, post-surgery, lower back pain, with a preemptive, drug-free pain management system. Its simple and brilliant. SynerFuse.

To learn more about SynerFuse, visit http://www.synerfuse.com/

Contact:
Justin Zenanko, Chief Executive Officer
612-217-2914
justin@synerfuse.com
https://www.linkedin.com/in/justin-zenanko-83641864/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved